146 related articles for article (PubMed ID: 36038153)
1. Fusion-negative rhabdomyosarcoma with diffuse bony metastases and remarkable chemosensitivity.
Kube P; Parisio K; Mangum DS; Powell J
BMJ Case Rep; 2022 Aug; 15(8):. PubMed ID: 36038153
[TBL] [Abstract][Full Text] [Related]
2. [Paratesticular rhabdomyosarcoma: a case report].
Chiba K; Kitami K; Kumagai H
Hinyokika Kiyo; 1990 Mar; 36(3):363-6. PubMed ID: 2191575
[TBL] [Abstract][Full Text] [Related]
3. Reduction of cyclophosphamide dose for patients with subset 2 low-risk rhabdomyosarcoma is associated with an increased risk of recurrence: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
Walterhouse DO; Pappo AS; Meza JL; Breneman JC; Hayes-Jordan A; Parham DM; Cripe TP; Anderson JR; Meyer WH; Hawkins DS
Cancer; 2017 Jun; 123(12):2368-2375. PubMed ID: 28211936
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow metastases at diagnosis in children and adolescents with rhabdomyosarcoma. A report from the intergroup rhabdomyosarcoma study.
Ruymann FB; Newton WA; Ragab AH; Donaldson MH; Foulkes M
Cancer; 1984 Jan; 53(2):368-73. PubMed ID: 6546301
[TBL] [Abstract][Full Text] [Related]
5. [A case of metastatic paratesticular rhabdomyosarcoma in an adult successfully treated with multidrug combination chemotherapy].
Kobayashi S; Tsukamoto T; Tohma T
Hinyokika Kiyo; 2010 Sep; 56(9):531-3. PubMed ID: 20940531
[TBL] [Abstract][Full Text] [Related]
6. [A case of paratesticular rhabdomyosarcoma].
Nishida A; Masuda F; Suzuki H; Kurauchi H; Mitani H; Kawahara M
Hinyokika Kiyo; 1990 Sep; 36(9):1089-92. PubMed ID: 2239618
[TBL] [Abstract][Full Text] [Related]
7. Addition of Vincristine and Irinotecan to Vincristine, Dactinomycin, and Cyclophosphamide Does Not Improve Outcome for Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group.
Hawkins DS; Chi YY; Anderson JR; Tian J; Arndt CAS; Bomgaars L; Donaldson SS; Hayes-Jordan A; Mascarenhas L; McCarville MB; McCune JS; McCowage G; Million L; Morris CD; Parham DM; Rodeberg DA; Rudzinski ER; Shnorhavorian M; Spunt SL; Skapek SX; Teot LA; Wolden S; Yock TI; Meyer WH
J Clin Oncol; 2018 Sep; 36(27):2770-2777. PubMed ID: 30091945
[TBL] [Abstract][Full Text] [Related]
8. Ifosfamide and etoposide are superior to vincristine and melphalan for pediatric metastatic rhabdomyosarcoma when administered with irradiation and combination chemotherapy: a report from the Intergroup Rhabdomyosarcoma Study Group.
Breitfeld PP; Lyden E; Raney RB; Teot LA; Wharam M; Lobe T; Crist WM; Maurer HM; Donaldson SS; Ruymann FB
J Pediatr Hematol Oncol; 2001 May; 23(4):225-33. PubMed ID: 11846301
[TBL] [Abstract][Full Text] [Related]
9. Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: children's oncology group study D9803.
Arndt CA; Stoner JA; Hawkins DS; Rodeberg DA; Hayes-Jordan AA; Paidas CN; Parham DM; Teot LA; Wharam MD; Breneman JC; Donaldson SS; Anderson JR; Meyer WH
J Clin Oncol; 2009 Nov; 27(31):5182-8. PubMed ID: 19770373
[TBL] [Abstract][Full Text] [Related]
10. Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial.
Bisogno G; De Salvo GL; Bergeron C; Gallego Melcón S; Merks JH; Kelsey A; Martelli H; Minard-Colin V; Orbach D; Glosli H; Chisholm J; Casanova M; Zanetti I; Devalck C; Ben-Arush M; Mudry P; Ferman S; Jenney M; Ferrari A;
Lancet Oncol; 2019 Nov; 20(11):1566-1575. PubMed ID: 31562043
[TBL] [Abstract][Full Text] [Related]
11. [A case of advanced paratesticular rhabdomyosarcoma].
Hiura M; Takenawa J; Ryoji O; Taki Y; Hayashi T; Kiriyama T
Hinyokika Kiyo; 1989 Jan; 35(1):141-6. PubMed ID: 2658509
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of topotecan and cyclophosphamide given in a phase II window trial in children with newly diagnosed metastatic rhabdomyosarcoma: a Children's Oncology Group study.
Walterhouse DO; Lyden ER; Breitfeld PP; Qualman SJ; Wharam MD; Meyer WH
J Clin Oncol; 2004 Apr; 22(8):1398-403. PubMed ID: 15007087
[TBL] [Abstract][Full Text] [Related]
13. Experimental chemotherapy and radiotherapy to paratesticular rhabdomyosarcoma.
Motoyama T; Watanabe H; Watanabe T; Yamamoto T
J Urol; 1989 Jan; 141(1):187-9. PubMed ID: 2908947
[TBL] [Abstract][Full Text] [Related]
14. Venoocclusive disease of the liver after chemotherapy with vincristine, actinomycin D, and cyclophosphamide for the treatment of rhabdomyosarcoma. A report of the Intergroup Rhabdomyosarcoma Study Group. Childrens Cancer Group, the Pediatric Oncology Group, and the Pediatric Intergroup Statistical Center.
Ortega JA; Donaldson SS; Ivy SP; Pappo A; Maurer HM
Cancer; 1997 Jun; 79(12):2435-9. PubMed ID: 9191535
[TBL] [Abstract][Full Text] [Related]
15. Paratesticular rhabdomyosarcoma: results of therapy in 18 cases.
Blyth B; Mandell J; Bauer SB; Colodny AH; Grier HE; Weinstein HJ; Tarbell NJ; Hendren WH; Retik AB
J Urol; 1990 Dec; 144(6):1450-3. PubMed ID: 2122010
[TBL] [Abstract][Full Text] [Related]
16. Comparison of dose intensity of vincristine, d-actinomycin, and cyclophosphamide chemotherapy for child and adult rhabdomyosarcoma: a retrospective analysis.
Kojima Y; Hashimoto K; Ando M; Yonemori K; Yamamoto H; Kodaira M; Yunokawa M; Shimizu C; Tamura K; Hosono A; Makimoto A; Fujiwara Y
Cancer Chemother Pharmacol; 2012 Sep; 70(3):391-7. PubMed ID: 22806306
[TBL] [Abstract][Full Text] [Related]
17. Rhabdomyosarcoma presenting as acute leukemia.
Morandi S; Manna A; Sabattini E; Porcellini A
J Pediatr Hematol Oncol; 1996 Aug; 18(3):305-7. PubMed ID: 8689348
[TBL] [Abstract][Full Text] [Related]
18. [Rhabdomyosarcoma of the bladder: a case report].
Kobayashi H; Kido K; Koie T; Ohyanagi H
Gan To Kagaku Ryoho; 1996 Feb; 23(3):365-8. PubMed ID: 8712832
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of vincristine, actinomycin-D, cyclophosphamide and irinotecan for patients with newly diagnosed low-risk subset B rhabdomyosarcoma: A study protocol.
Miyachi M; Tsuchiya K; Hosono A; Ogawa A; Koh K; Kikuta A; Hara J; Teramukai S; Hosoi H
Medicine (Baltimore); 2019 Dec; 98(52):e18344. PubMed ID: 31876708
[TBL] [Abstract][Full Text] [Related]
20. [PRIMARY PROSTATIC RHABDOMYOSARCOMA WITH REPEATING CEREBRAL HEMORRHAGE FROM BRAIN METASTASES IN AN ADULT: A CASE REPORT].
Tochigi K; Sassa N; Kanada Y; Ohashi T; Inoue S; Takai S; Matsuo K; Majima T; Ishida S; Funahashi Y; Fujita T; Matsukawa Y; Kato M; Yamamoto T; Gotoh M
Nihon Hinyokika Gakkai Zasshi; 2019; 110(2):119-123. PubMed ID: 32307379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
